Growing community of inventors

Guilford, CT, United States of America

Neil Beeharry

Average Co-Inventor Count = 7.58

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 20

Neil BeeharryJonathan Marc Rothberg (8 patents)Neil BeeharryHenri Lichenstein (8 patents)Neil BeeharrySean Landrette (8 patents)Neil BeeharryTian Xu (7 patents)Neil BeeharryPaul Beckett (7 patents)Neil BeeharryChris Conrad (7 patents)Neil BeeharryJonathan M Rothberg (7 patents)Neil BeeharrySophia Gayle (6 patents)Neil BeeharryMatt Dyer (2 patents)Neil BeeharryMarylens Hernandez (1 patent)Neil BeeharryTian Xu (1 patent)Neil BeeharryTian Xu (0 patent)Neil BeeharryNeil Beeharry (8 patents)Jonathan Marc RothbergJonathan Marc Rothberg (402 patents)Henri LichensteinHenri Lichenstein (31 patents)Sean LandretteSean Landrette (13 patents)Tian XuTian Xu (27 patents)Paul BeckettPaul Beckett (9 patents)Chris ConradChris Conrad (7 patents)Jonathan M RothbergJonathan M Rothberg (7 patents)Sophia GayleSophia Gayle (6 patents)Matt DyerMatt Dyer (4 patents)Marylens HernandezMarylens Hernandez (2 patents)Tian XuTian Xu (1 patent)Tian XuTian Xu (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Ai Therapeutics, Inc. (5 from 14 patents)

2. Lam Therapeutics, Inc. (2 from 2 patents)

3. A1 Therapeutics, Inc. (1 from 1 patent)


8 patents:

1. 11266654 - Apilimod compositions and methods for using same

2. 11166944 - Apilimod compositions and methods for using same in the treatment of renal cancer

3. 10799508 - Methods for treating cancer using HSP90 inhibitors

4. 10765682 - Apilimod for use in the treatment of melanoma

5. 10729694 - Anti-viral compositions containing PIKfyve inhibitors and use thereof

6. 10350213 - Methods for treating cancer using apilimod

7. 10206910 - Apilimod for use in the treatment of renal cancer

8. 10179135 - Apilimod compositions and methods for using same

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/1/2026
Loading…